A Study of Parsaclisib, a PI3Kδ Inhibitor, in Combination With Bendamustine and Rituximab in Patients With Newly Diagnosed Mantle Cell Lymphoma
Clinical trial NCT04849715 · WITHDRAWN
Trial details
- NCT number
- NCT04849715
- Sponsor
- Incyte Corporation
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-11
- Primary completion
- 2030-08-15
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.